Eurasian Hematology-Oncology Group

http://www.ehog.net/

 

IO for R/R cHL: Optimal Treatment Regimen, Therapy Duration & Discontinuation, Prognostic Factors, Treatment Strategy in Case of Resistance

0 views
January 12, 2021
Comments 0
Login to view comments. Click here to Login